• To be able to describe the epidemiology, aetiology and risk factors of ovarian cancer

  • To be able to perform specialist assessment and to develop a multidisciplinary management plan for newly diagnosed patients with ovarian cancer

  • To be able to formulate treatment plans for patients with recurrent ovarian cancer, including palliation

  • Awareness of risk factors

  • Awareness of symptoms and signs

  • Appreciation of the evidence for screening and preventive measures

  • Recognition of the genetic predisposition to ovarian cancer

  • Awareness of imaging modalities and serum markers to diagnose and manage patients with ovarian cancer

  • Appreciation of fertility preservation options

  • Appreciation of issues surrounding management of ovarian cancer in pregnancy

  • Awareness of survivorship-related issues

  • Familiarity with the anatomy related to ovarian cancer

  • Knowledge of the staging systems used in ovarian cancer

  • Familiarity with the histological and molecular subtypes of ovarian cancer and the associated clinical behaviour

  • Understanding of the relevance of BReast CAncer (BRCA) testing in ovarian cancer

  • Understanding of the management of newly diagnosed (first-line) ovarian cancer:

    • Evidence for and role of primary debulking surgery, primary chemotherapy and interval debulking surgery

    • Evidence and indications for adjuvant systemic therapy (including antiangiogenic therapy, dose-dense and intraperitoneal chemotherapy)

    • Surgical management: first-line, recurrent, palliative

  • Understanding of the management of recurrent ovarian cancer:

    • Familiarity with the relevance of treatment-free interval

    • Platinum-sensitive, platinum-resistant and platinum-refractory (chemotherapy and targeted therapy options such as antiangiogenic therapy and poly ADP ribose polymerase (PARP) inhibitors)

    • Role for surgery in relapsed disease, including palliative procedures, eg, in case of bowel obstruction

  • Knowledge of an overview of the management of non-epithelial ovarian cancers and ovarian tumours, eg, sex-cord stromal ovarian tumours, borderline tumours

  • Ability to contribute to the multidisciplinary management decisions of patients with newly diagnosed and recurrent ovarian cancer

  • Ability to determine and prescribe systemic therapy plans for newly diagnosed and recurrent patients with ovarian cancer, taking into consideration performance status, comorbidities and prior toxicities

  • Ability to evaluate patients for therapy (history and physical examination, including internal) and to discuss prognosis and treatment options

  • Ability to counsel patients regarding the relevance of BRCA gene testing

  • Ability to assess and manage disease-related events (eg, ascites, bowel obstruction), and complications of systemic therapies

  • Ability to discuss cancer follow-up with patients